ViaDerma Completes First Shipment of 500,000 Units to Nigeria
10 sept. 2024 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a specialty pharmaceutical company known for developing innovative transdermal drug delivery systems, is pleased to...
ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria
13 août 2024 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a leader in innovative wound care solutions, is excited to announce that a shipment of 500,000 units of its flagship...
ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires
01 août 2024 08h00 HE
|
ViaDerma, Inc.
ViaDerma announces strategic new agreements to move forward its global expansion.
ViaDerma Provides Highlights of Quarterly Financial Report
06 juin 2024 08h00 HE
|
ViaDerma, Inc.
ViaDerma provides an update on their most recent quarterly financial report
ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More
06 juil. 2023 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is very pleased to announce several exciting business updates for current and prospective shareholders, partners, and...
ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
16 mars 2023 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, March 16, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce that the company has recently submitted their application for their planned minoxidil hair...
ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development
12 janv. 2023 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (OTC Pink: VDRM) is pleased to announce that they have engaged the growth marketing services of INTENT SCIENCES who will help grow the...
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
31 mars 2022 05h00 HE
|
ViaDerma, Inc.
LOS ANGELES, March 31, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces the release of its 2021 Annual Report on the OTC Markets. The Company ended the year with...
ViaDerma, Inc. Files Amended Financial Statements
24 août 2021 10h23 HE
|
ViaDerma, Inc.
LOS ANGELES, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) published a Quarterly Report for the three months ended March 31, 2021, on the OTC Markets website...
ViaDerma, Inc. Announces Expansion of its Current Licensing Agreement and Provides Additional Company Updates
02 juin 2021 05h00 HE
|
ViaDerma, Inc.
LOS ANGELES, June 02, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to announce they have expanded their current licensing agreement with a home health wound care...